Selecting and Using the Appropriate Influenza Vaccine for Each Individual
- PMID: 34073843
- PMCID: PMC8225103
- DOI: 10.3390/v13060971
Selecting and Using the Appropriate Influenza Vaccine for Each Individual
Abstract
Despite seasonal influenza vaccines having been routinely used for many decades, influenza A virus continues to pose a global threat to humans, causing high morbidity and mortality each year. The effectiveness of the vaccine is largely dependent on how well matched the vaccine strains are with the circulating influenza virus strains. Furthermore, low vaccine efficacy in naïve populations such as young children, or in the elderly, who possess weakened immune systems, indicates that influenza vaccines need to be more personalized to provide broader community protection. Advances in both vaccine technologies and our understanding of influenza virus infection and immunity have led to the design of a variety of alternate vaccine strategies to extend population protection against influenza, some of which are now in use. In this review, we summarize the progress in the field of influenza vaccines, including the advantages and disadvantages of different strategies, and discuss future prospects. We also highlight some of the challenges to be faced in the ongoing effort to control influenza through vaccination.
Keywords: pandemic preparedness; priming immune response; seasonal influenza vaccine; whole virus particle vaccine.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Advances in the development of universal influenza vaccines.Influenza Other Respir Viruses. 2013 Sep;7(5):750-8. doi: 10.1111/irv.12013. Epub 2012 Sep 24. Influenza Other Respir Viruses. 2013. PMID: 22998622 Free PMC article. Review.
-
Vaccines for seasonal and pandemic influenza.J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8. doi: 10.1086/507544. J Infect Dis. 2006. PMID: 17163383
-
New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.Vaccine. 2013 Apr 17;31 Suppl 1:A1-20. doi: 10.1016/j.vaccine.2013.02.033. Vaccine. 2013. PMID: 23587330
-
Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.Pediatr Infect Dis J. 2009 Jul;28(7):563-71. doi: 10.1097/INF.0b013e31819d6394. Pediatr Infect Dis J. 2009. PMID: 19561422 Clinical Trial.
-
Current challenges: from the path of "original antigenic sin" towards the development of universal flu vaccines.Int Rev Immunol. 2020;39(1):21-36. doi: 10.1080/08830185.2019.1685990. Epub 2019 Nov 9. Int Rev Immunol. 2020. PMID: 31707873 Review.
Cited by
-
The Impact of Vaccinations Against Respiratory Infections on the Prognosis in Heart Failure Patients.Vaccines (Basel). 2024 Nov 26;12(12):1321. doi: 10.3390/vaccines12121321. Vaccines (Basel). 2024. PMID: 39771983 Free PMC article. Review.
-
Nanoparticle‑based antiviral strategies to combat the influenza virus (Review).Biomed Rep. 2024 Feb 21;20(4):65. doi: 10.3892/br.2024.1753. eCollection 2024 Apr. Biomed Rep. 2024. PMID: 38476608 Free PMC article. Review.
-
Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons.PLoS One. 2024 Jun 25;19(6):e0301157. doi: 10.1371/journal.pone.0301157. eCollection 2024. PLoS One. 2024. PMID: 38917104 Free PMC article.
-
Special Issue-Immunity to Influenza Viruses.Viruses. 2022 Feb 3;14(2):319. doi: 10.3390/v14020319. Viruses. 2022. PMID: 35215910 Free PMC article.
-
Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium.Front Immunol. 2025 May 23;16:1568778. doi: 10.3389/fimmu.2025.1568778. eCollection 2025. Front Immunol. 2025. PMID: 40486504 Free PMC article.
References
-
- WHO Seasonal Influenza Fact Sheet. [(accessed on 12 February 2021)]; Available online: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
-
- Grohskopf L.A., Alyanak E., Broder K.R., Blanton L.H., Fry A.M., Jernigan D.B., Atmar R.L. Prevention and control of seasonal influenza with vaccines: Recommendations of the advisory committee on immunization practices—United States, 2020–2021 influenza season. MMWR Recomm. Rep. 2020;69:1–24. doi: 10.15585/mmwr.rr6908a1. - DOI - PMC - PubMed
-
- Rolfes M.A., Foppa I.M., Garg S., Flannery B., Brammer L., Singleton J.A., Burns E., Jernigan D., Olsen S.J., Bresee J., et al. Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness. Influenza Other Respir. Viruses. 2018;12:132–137. doi: 10.1111/irv.12486. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical